Justin Piro
About Justin Piro
Justin Piro is the Director of Neuroinflammation & Glial Biology at Alkermes, with over a decade of experience in the field and a strong background in biochemistry.
Title and Current Role
Justin Piro is the Director of Neuroinflammation & Glial Biology at Alkermes. He has held this position since December 2020, overseeing research and development in the field of neuroinflammation and glial biology.
Past Experience at AbbVie
Before joining Alkermes, Justin Piro worked at AbbVie as Principal Research Scientist II. His tenure at AbbVie lasted from 2018 to 2020, during which he focused on neuroinflammation projects. His work at AbbVie was based in Cambridge, MA.
Experience at Pfizer
Justin Piro's career includes a significant stint at Pfizer, where he served as Principal Scientist from 2011 to 2018. During his seven years at Pfizer in Cambridge, MA, he engaged in extensive research on neuroinflammation and CNS disorders.
Educational Background
Justin Piro has a robust academic background in biochemistry. He earned his Ph.D. in Biochemistry from Dartmouth College, where he studied from 2005 to 2011. Prior to that, he obtained a B.S. in Biochemistry from Eastern Connecticut State University, completing his undergraduate studies between 2001 and 2005.
Research Experience in Neuroinflammation
With over a decade of experience, Justin Piro has dedicated a significant portion of his career to research in neuroinflammation and glial biology. His work on CNS disorders spans across his roles at major pharmaceutical companies, including Pfizer and AbbVie, and continues in his current position at Alkermes.